INS and type 2 diabetes mellitus: In a significant portion of Type 2 diabetic patients, the disease progresses to a complete loss of β-cell insulin secretion [6], thus necessitating exogenous administration of insulin, in addition to other medications, to achieve adequate glycemic control [7, 8].